Table 2.
Details of antibody titers in the CSF and serum of patients who were positive for two antibody types concurrently.
| Antibodies | Cases | Antibody titer |
|---|---|---|
| NMDAR + GABABR | Case 1 | CSF NMDAR: weakly positive GABABR: positive Serum GABABR: positive |
| Case 2 | CSF NMDAR: positive GABABR: positive Serum NMDAR: positive GABABR: positive | |
| Case 3 | CSF NMDAR: positive GABABR: positive Serum NMDAR: positive GABABR: positive | |
| LGI1+ CASPR2 | Case 1 | CSF LGI1: positive CASPR2: strongly positive Serum Negative |
| Case 2 | CSF Negative Serum LGI1: weakly positive CASPR2: positive | |
| Case 3 | CSF Negative Serum LGI1: weakly positive CASPR2: positive | |
| NMDAR + CASPR2 | Case 1 | CSF NMDAR: positive Serum NMDAR: weakly positive CASPR2: weakly positive |
| AMPA2 receptor + CASPR2 | Case 1 | CSF AMPA2 receptor: positive Serum AMPA2 receptor: weakly positive CASPR2: weakly positive |